News – Page 373 – Endpoints News

FDA advisors unanimously recommend accelerated approval for Biogen's ALS drug

3 years ago

Incyte wins accelerated approval for PD-1 in rare skin cancer

3 years ago

Federal judge denies Amgen's motion to dismiss Regeneron antitrust case

3 years ago

Regeneron scores label expansion for cholesterol drug Evkeeza

3 years ago

Social media patient influencers ‘dancing in the gray’ of pharma marketing, more clarity needed, researcher says

3 years ago

Novartis pulls the plug on UK-based cardiovascular study

3 years ago

Drug shortage solutions brought before Senate Homeland Security committee

3 years ago

Moderna CEO defends Covid-19 vaccine price change at Senate committee grilling

3 years ago

FDA rejects AbbVie's infusion therapy for Parkinson's, requests more info on pump device

3 years ago

Biohaven grabs TYK2/JAK1 drug for $20M to start, $950M on the line — to go after Parkinson's

3 years ago

Quince Therapeutics faces takeover bid from shareholder Echo Lake Capital

3 years ago

Astellas fleshes out more PhIII data for Claudin 18.2 drug

3 years ago

FDA+ roundup: Legislative asks for 2024 focus on more authorities, generic drug competition

3 years ago

In insulin resistance pact, Dewpoint adds Novo Nordisk to its pharma-rich pipeline

3 years ago

Novartis touts seven years of durability data for Zolgensma

3 years ago

'Banding together': 50 female biotech executives lay out plans for board diversity, new companies and mentoring ...

3 years ago

The venture crew at Mubadala are upping their biotech creation game, taking careful aim at a new frontier in drug ...

3 years ago

Roche and Lilly team up to develop blood test to detect early signs of Alzheimer's

3 years ago

89bio’s PhII data add to quick succession of NASH readouts as field seeks turnaround

3 years ago

A $123M Flare will get Third Rock oncology biotech into the clinic this year

3 years ago

Exclusive: After getting his drug back, Landos founder assembles new startup for the big PhIII test

3 years ago

NIH rejects another attempt to 'march-in' on Astellas' prostate cancer drug over excessive price

3 years ago

FDA warns Procter & Gamble over NyQuil label's ingredient listings

3 years ago

FTC says patent battle over Parkinson's drug could have 'significant implications' for patients

3 years ago

First page Previous page 370 371 372373374 375 376 Next page Last page